Cambridge Consultants Logo

Site Map Legals
 

Corporate Design and Development Intellectual Property Consulting Media Centre Recruitment
Corner
Press Releases
Press Contacts
Image Gallery
Expert Comment
Press Archives
  Stay In Touch  
Contact Us
interface 44

 

 

 

Media Centre
media centre>

     Email Story       Print

 
25 September 2003

Taking the tears out of asthma

Two new concepts from leading European design and development company, Cambridge Consultants Ltd (CCL) aim to take the worry and stigma out of being a child with asthma. The number of children with asthma is growing. Already, it affects one in ten children throughout Europe, and the number of people recorded with asthma has doubled in the past decade.

In some countries such as Canada, Australia and the UK, the prevalence of children suffering with the disease is as high as 30%.

Despite these worrying statistics, childhood asthma management can be improved. Children can frequently be worried or stigmatised by current treatment practices that involve the use of a ‘spacer’ attached to a normal asthma inhaler and consequently may not use the device properly. Through the use of innovative design, engineers at CCL intend to make these drawbacks a thing of the past and deliver better asthma treatment for children across the world.

Successful treatment of asthma is directly linked to correct usage of the inhaler and its associated spacer, and the willingness of the child to use the apparatus. Many children up to the age of 15, but especially those under the age of 5, are unable to co-ordinate activating the inhaler and simultaneously breathing. Further, they often cannot manage to achieve the required minimum respiratory flow that allows the drug to be successfully delivered to the affected area of lung and bronchial tract. Spacers help children to get over both of these problems although, with being a large balloon-like piece of hollow transparent plastic, many find them cumbersome to carry around and they can worry small children when they first learn to use them. It is not unknown for children to carry a packed-lunch box just to transport their spacer, although the very process of doing so can mark them out from other children.

Engineers in CCL’s Drug Delivery group set about tackling the problem of how to make spacers appealing to children under the age of 15 whilst retaining device efficacy for successful treatment. CCL’s philosophy is that sources of innovation are all around us, but that you just need to know where to look. To tackle this problem the team turned to children’s toys, the ancient art of origami, and a toddler’s teaspoon to create a range of new concepts.

For hundreds of years the Japanese have been folding paper into decorative and useful shapes. Using similar principles Cambridge Consultants has designed a low cost collapsible spacer that allows patients to keep their spacer in their pocket. The spacers can be made from card or plastic and they offer significant benefits in a low cost device. Designs, or images of the latest super-hero or pop star could be printed onto the spacers so as to increase the attractiveness of the device. With a product made from card, and therefore disposable on a weekly basis, the design can even keep pace with children’s quickly changing tastes and trends.

Another idea was inspired by a ‘Jack in the Box’. A spring-loaded spacer has been designed that in its open state offers all the benefits of a standard spacer but by compressing the spring the patient is able to store the compact device in their pocket.

Further designs have been created to improve the image of spacers and increase their attractiveness to children. One such design uses thermochromatic plastics that change colour with temperature. These plastics are used in some children’s teaspoons to cause the spoon to change colour indicating the food is still too hot. Manufacturing the spacers out of these plastics allows the use of the spacer to be rewarded with the appearance of images or patterns as the body heat increases the temperature of the plastic.

Jon Tuckwell, who heads CCL’s Drug Delivery Group commented, "With as many as one in three children suffering with asthma, I’m amazed that little has been done to improve the problems associated with using a spacer. Whilst the disease is well understood and can be well treated, it is critical that the child is willing to use the delivery device. If they are unwilling to be seen carrying or using a spacer then they simply will not be getting the treatment they need. We know that certain devices,
such as mobile phones, are seen as the ‘cool’ accessories to have in the playground. My aim in this development is to take the cool elements and apply them to this problem."

The combination of science and design techniques to create new designs such as those described above has been shown to greatly improve the appeal of the spacers. The result is improved delivery of drug to the lungs, reduced systemic side effects and hence better asthma management for children across the world. Cambridge Consultants is currently discussing its patented concepts with a number of leading healthcare companies.

Initial research into the problems associated with treating children with asthma was conducted with the valuable support of the asthma nurses at Addenbrooke’s Hospital.

Downloadable images are available from our media centre

Some Facts About Asthma

  • With 100-150 million people with Asthma world-wide, the WHO (World Health Organisation) estimate that more than 180,000 people die from it each year.
  • Each year in the United States 150,000 children are hospitalised by their asthma and almost 5,000 children die from their condition; National Vital Statistics Reports, Vol. 49, No. 8, CDC
  • In the USA Asthma is the third leading cause of hospitalisation among children under the age of 15 and it is the first-ranking chronic condition; American Lung Association
  • In the USA, Asthma accounts for 14 million lost school days annually. It is the leading cause of school absenteeism attributed to chronic conditions, and the estimated annual cost of treating asthma in those under 18 years of age is $3.2 billion; American Lung Association
  • 5.1 million people in the UK are currently receiving treatment for asthma: 1.4 million children (1 in 8) and 3.7 million adults (1 in 13); National Asthma Campaign
  • On average 1,500 people die from asthma each year in the UK – at least a third of those are under the age of 65. This is four people per day, or one person every six hours ; National Asthma Campaig
  • Every 16 minutes a child is admitted to hospital in England, Scotland or Wales because of their asthma; National Asthma Campaign
  • The UK has the highest prevalence of severe wheeze in children aged 13–14 years worldwide; National Asthma Campaign
Notes for editors:
Cambridge Consultants Limited (CCL) designs and develops innovative new products, processes and systems. The organization enables clients to turn business opportunities into commercial successes, whether launching first-to-market products, or expanding existing markets through the introduction of new technologies. With a team of over 250 engineers and scientists, CCL is able to offer solutions across a diverse range of industries including healthcare, telecommunications, industrial and consumer products, automotive and aerospace. Operating from purpose-built laboratories on the Cambridge Science Park, CCL works for multinationals and small companies alike.

 

 

Patrick Pordage
Marketing Communications Manager
Cambridge Consultants Ltd
Tel: 01223 420024
Patrick.Pordage@CambridgeConsultants.com

www.CambridgeConsultants.com

 

 
tel: (UK) +44 (0)1223 420024 (US) + 1 617 532 4700